Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature

Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime–avibactam as a therapy for...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Alessandro Mancuso, Luca Pipitò, Raffaella Rubino, Salvatore Antonino Distefano, Donatella Mangione, Antonio Cascio
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2023-08-01
סדרה:	Antibiotics
נושאים:	ceftazidime–avibactam osteomyelitis arthritis <i>Pseudomonas aeruginosa</i>
גישה מקוונת:	https://www.mdpi.com/2079-6382/12/8/1328
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!